Model
Edge
Centessa Pharmaceuticals
CNTA
Filing Type
8-K
Filing Date
6/23/2026
Updated
6/24/26, 7:00 AM
Copy Ref
Filing
8-K
Earnings Release
Exhibits
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events